XIFIN Named an 11th Time Honoree on Inc. 5000 List of Fastest-Growing Private Companies in America
XIFIN Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, and a Frost & Sullivan’s 2017 North American Revenue Cycle Management Company of the Year in the diagnostic laboratory segment, placed on the 2017 Inc. 5000 Fastest-Growing Private U.S. Companies list for the eleventh time — an accomplishment achieved by only a very select group...
Frost & Sullivan Honors XIFIN with Prestigious 2017 North American Revenue Cycle Management for Diagnostic Laboratories Company of the Year Award
XIFIN Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, has been named Frost & Sullivan’s 2017 North American Revenue Cycle Management Company of the Year in the diagnostic laboratory segment. Frost & Sullivan analysts followed a proprietary 10-step process to assess XIFIN’s fit against select best practice criteria...
XIFIN Partners with PWNHealth to Offer Lab Services for Direct-to-Consumer Testing, Employer-Based Screening, and Telegenetic Counseling
Services Provide New Growth Opportunities for XIFIN Customers XIFIN Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, today announced a partnership agreement with PWNHealth LLC, a virtual care company offering safe and easy access to diagnostic testing services and professional guidance. The agreement allows XIFIN to market PWN’s services...
Attention CFOs of Clinical Lab Companies, Hospitals, and Health Systems: Coming Soon is New FASB Requirement for Recognizing Revenue from Contracts
Big changes are coming for chief financial officers at laboratory companies, hospitals, and health systems that report financial performance using GAAP. CFOs at these organizations will soon be required to comply with the new FASB Rule 606–Revenue Recognition Standard. That means all contracts, including managed care contracts and patient self-pay arrangements, must be reported in a different...
Former Pathology, Inc. CEO Vicki DiFrancesco Joins XIFIN as Chief Strategy Officer
XIFIN Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, has appointed Vicki DiFrancesco as its Chief Strategy Officer. DiFrancesco, one of the most influential leaders in the laboratory industry, will be responsible for building and executing XIFIN’s corporate business development strategies including acquisitions, joint ventures and...
XIFIN Executive Leadership to Present Sessions at 22nd Annual Executive War College on How to Prepare for the Financial Impact of PAMA and Strategies for Molecular & Genetic Testing Success
XIFIN Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, today announced that Lâle White, Executive Chairman and CEO, and Kyle Fetter, VP of Advanced Diagnostics, will be speaking at the 22nd annual Executive War College Conference on Laboratory & Pathology Management to be held May 2-3, 2017 at the Sheraton Hotel in New Orleans, LA....
XIFIN Executives to Present Sessions on Collaborative Diagnostic Workflows and Novel Diagnostic Technologies at 24th International Molecular Medicine Tri-Conference
XIFIN Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, will co-present a session with the University of Chicago on collaborative diagnostic workflows at the Cambridge Healthtech Institute’s Fifth Annual Digital Pathology conference, a track at the 24th International Molecular Medicine Tri-Conference being held February 20-22 at the...
XIFIN Continues Distinguished Ranking on Inc. 5000 List of Fastest-Growing Private Companies in America Earning its Tenth Listing
For the tenth year, XIFIN, Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, and a recognized five-time Inc. 5000 Honor Roll company, placed on the 2016 Inc. 5000 Fastest-Growing Private U.S. Companies list for the tenth time — an accomplishment achieved by only 1 percent of the companies listed on the Inc. 5000. In its 35th annual list,...
- 1 of 12
- next ›